missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human IFN-gamma Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 3 publications
Brand: R&D Systems MAB2851-100
This item is not returnable.
View return policy
Description
IFN-gamma Monoclonal specifically detects IFN-gamma in Human samples. It is validated for Neutralization, Intracellular Staining by Flow Cytometry, Immunocytochemistry, CyTOF-ready.
Specifications
| IFN-gamma | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| IFG, IFI, IFNG, IFNgamma, IFN-gamma, Immune interferon, interferon gamma, interferon, gamma | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 3458 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG2b |
| Neutralization, Flow Cytometry, Immunocytochemistry, CyTOF | |
| 25723 | |
| Neutralization 0.2- 0.6 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready | |
| AAP20098.1 | |
| IFNG | |
| E. coli-derived recombinant human IFN-gamma Gln24-Gln166 Accession # AAP20098.1 | |
| 100 μg | |
| Primary | |
| Detects human IFN-gamma in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant mouse IFN-gamma , recombinant rat IFN-gamma , or recombinant porcine IFN-gamma is observed. Neutralizes the bioactivity of recombinant human IFN-gamma and will not neutralize the activity of rat or mouse IFN-gamma . | |
| Human | |
| Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction